A Retrospective Comparison Study Between the Effectiveness and Safety of Fixed Dose Combination of Vildagliptin Versus Sitagliptin With Metformin in Type 2 Diabetes Mellitus Patients

Indian Journal of Pharmacy Practice
doi 10.5530/ijopp.11.4.37
Full Text
Abstract

Available in full text

Date
Authors
Publisher

EManuscript Services

Related search

Comparison of the Effectiveness and Safety of Vildagliptin Add-On to Metformin Versus Other Oral Dual Antidiabetes Agents in Patients With Type 2 Diabetes: The China Prospective Diabetes Study

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

A Prospective Open Labelled Study of Effect of Vildagliptin With Metformin in Patients With Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2019English

Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2017English

Cardiovascular Safety of Sitagliptin in Patients With Type 2 Diabetes Mellitus: A Pooled Analysis

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Pharmacoeconomic Analysis of the Use of a Fixed Dose Combination of Metformin and Glibenclamide in the Therapy of Diabetes Mellitus Type 2

Pharmacoeconomics: theory and practice
2016English

Repaglinide/Metformin Fixed-Dose Combination to Improve Glycemic Control in Patients With Type 2 Diabetes: An Update

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2010English

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

JAMA - Journal of the American Medical Association
Medicine
2000English

Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes

Scientific Reports
Multidisciplinary
2019English

Pioglitazone and Metformin Fixed-Dose Combination in Type 2 Diabetes Mellitus: An Evidence-Based Review of Its Place in Therapy

Core Evidence
MedicineReviewsReferencesPharmacology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy